Bioceres Crop Solutions to Host Fiscal First Quarter 2025 Financial Results Conference Call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time
Bioceres Crop Solutions (NASDAQ: BIOX), a company focused on agricultural ecosystem regeneration and climate-resilient crop solutions, announces its fiscal first quarter 2025 earnings conference call. The call is scheduled for Tuesday, November 12, 2024, at 8:30 a.m. Eastern Time. The company will release detailed financial results for the quarter ended September 30, 2024, before the call. The presentation will be hosted by CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of IR Paula Savanti, followed by a Q&A session. A replay will be available through November 19, 2024.
Bioceres Crop Solutions (NASDAQ: BIOX), un'azienda focalizzata sulla rigenerazione degli ecosistemi agricoli e soluzioni per coltivazioni resilienti ai cambiamenti climatici, annuncia la sua call per gli utili del primo trimestre fiscale 2025. La chiamata è programmata per martedì 12 novembre 2024, alle 8:30 ora orientale. L'azienda pubblicherà i risultati finanziari dettagliati per il trimestre conclusosi il 30 settembre 2024, prima della chiamata. La presentazione sarà ospitata dal CEO Federico Trucco, dal CFO Enrique Lopez Lecube e dalla Responsabile delle Relazioni con gli Investitori Paula Savanti, seguita da una sessione di domande e risposte. Una registrazione sarà disponibile fino al 19 novembre 2024.
Bioceres Crop Solutions (NASDAQ: BIOX), una empresa centrada en la regeneración de ecosistemas agrícolas y soluciones de cultivos resilientes al clima, anuncia su llamada de ganancias del primer trimestre fiscal 2025. La llamada está programada para el martes 12 de noviembre de 2024, a las 8:30 a.m. hora del este. La empresa publicará resultados financieros detallados para el trimestre terminado el 30 de septiembre de 2024, antes de la llamada. La presentación será dirigida por el CEO Federico Trucco, el CFO Enrique Lopez Lecube y la Jefa de Relaciones con Inversores Paula Savanti, seguida de una sesión de preguntas y respuestas. Una repetición estará disponible hasta el 19 de noviembre de 2024.
Bioceres Crop Solutions (NASDAQ: BIOX), 농업 생태계 재생 및 기후 회복력이 있는 작물 솔루션에 중점을 둔 회사입니다. 2025 회계 년도 첫 분기 실적 컨퍼런스 콜을 발표합니다. 콜은 2024년 11월 12일 화요일, 동부 표준시 기준 오전 8:30에 예정되어 있습니다. 회사는 콜 전에 2024년 9월 30일 종료된 분기의 상세 재무 결과를 발표할 것입니다. 프레젠테이션은 CEO Federico Trucco, CFO Enrique Lopez Lecube 및 IR 책임자인 Paula Savanti가 진행하며, Q&A 세션이 이어집니다. 재방송은 2024년 11월 19일까지 이용 가능합니다.
Bioceres Crop Solutions (NASDAQ: BIOX), une entreprise axée sur la régénération des écosystèmes agricoles et des solutions de cultures résilientes au climat, annonce sa conférence téléphonique sur les résultats du premier trimestre fiscal 2025. L'appel est prévu pour mardi 12 novembre 2024, à 8h30, heure de l'Est. L'entreprise publiera les résultats financiers détaillés pour le trimestre clos le 30 septembre 2024, avant l'appel. La présentation sera animée par le PDG Federico Trucco, le CFO Enrique Lopez Lecube et la Responsable des IR Paula Savanti, suivie d'une séance de questions-réponses. Un replay sera disponible jusqu'au 19 novembre 2024.
Bioceres Crop Solutions (NASDAQ: BIOX), ein Unternehmen, das sich auf die Regeneration landwirtschaftlicher Ökosysteme und klimaresiliente Anbaulösungen konzentriert, kündigt seine Earnings-Call für das erste Quartal des Geschäftsjahres 2025 an. Der Anruf ist für Dienstag, den 12. November 2024, um 8:30 Uhr Eastern Time geplant. Das Unternehmen wird die detaillierten Finanzergebnisse für das am 30. September 2024 endende Quartal vor dem Anruf veröffentlichen. Die Präsentation wird von CEO Federico Trucco, CFO Enrique Lopez Lecube und Leiterin der IR Paula Savanti geleitet, gefolgt von einer Q&A-Sitzung. Eine Aufzeichnung wird bis zum 19. November 2024 verfügbar sein.
- None.
- None.
Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the company’s website here.
To access the call, please use the following information:
Date: |
Tuesday, November 12, 2024 |
Time: |
8:30 a.m. ET, 5:30 a.m. PT |
US Toll Free dial-in number: |
1-833-470-1428 |
International dial-in numbers: |
Click here |
Conference ID: |
305729 |
Webcast: |
Click here |
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.
The conference call will be broadcast live and available for replay here and via the investor relations section of the company’s website here.
A replay of the call will be available through November 19, 2024 following the conference.
US Toll Free Replay Number: |
1-866-813-9403 |
International dial-in numbers: |
Click here |
Replay ID: |
649318 |
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit here.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031559618/en/
Investor Relations Contact
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com
Source: Bioceres Crop Solutions Corp.
FAQ
When will Bioceres Crop Solutions (BIOX) report Q1 2025 earnings?
How can I access Bioceres Crop Solutions (BIOX) Q1 2025 earnings call?